Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
larotrectinib
3
×
life sciences
loxo oncology
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trials
fda
keytruda
merck
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
avrobio
blueprint medicines
What
cancer
annual
clinical
drug
oncology
society
today
ahead
ambien
american
approved
asco
attendees
attention
biotech
breast
camp’s
cancer's
cash
chicago
city
combinations
community’s
conference
data
days
deeper
dna
esmo
european
expanding
fda
fingerprint
focus
genetic
going
home
key
kicks
lines
Language
Current search:
larotrectinib
×
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
